Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS
Articolo
Data di Pubblicazione:
2014
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Khatri, Bo; Pelletier, J; Kappos, L; Hartung, Hp; Comi, Giancarlo; Barkhof, F; von Rosenstiel, P; Meng, X; Grinspan, A; Hashmonay, R; Cohen, Ja; TRANSFORMS Study, Group
Link alla scheda completa:
Pubblicato in: